January 11, 2018 / 9:46 PM / 10 days ago

BRIEF-Dynasil Announces Submission Of Xcede Technologies' Application For First-In-Human Clinical Trial

Jan 11 (Reuters) - Dynasil Corporation Of America:

* DYNASIL ANNOUNCES SUBMISSION OF XCEDE TECHNOLOGIES’ APPLICATION FOR FIRST-IN-HUMAN CLINICAL TRIAL

* DYNASIL CORPORATION OF AMERICA - ‍ANTICIPATES THAT PATIENTS WILL BE TREATED WITH XCEDE PATCH IN NETHERLANDS IN EARLY 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below